MedPath

Characterization and evaluation of the safety and effectiveness of human umbilical cord blood serum alginate hydrogel on patients with 2A degree burns.

Phase 1
Conditions
2A degree burns.
Burn of second degree, body region unspecified
T30.2
Registration Number
IRCT20221130056672N3
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Men and women aged 18 to 60 who have 2A degree burns with a burn percentage of less than 15% of the body surface.
The dimensions of the burn wound should be 10 x 10 cm.
Willingness to participate in research and able to answer questions.

Exclusion Criteria

Have underlying diseases and immune system defects such as diabetes, cancer, AIDS, high blood pressure and skin allergies.
Before entering the sample into the research, they have used a substance other than drinking water on the wound.
A person with symptomatic infection in different parts of the body.
Burns in the face and genital area.
More than 48 hours have passed from the time of the burn to the time of entering the study.
According to the doctor's opinion, the person needs to be hospitalized.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Healing time. Timepoint: Measurement of healing time on days 0 (before the intervention), 7 and 14. Method of measurement: Photography with Image J software.
Secondary Outcome Measures
NameTimeMethod
The amount of pain. Timepoint: Pain measurement on days 0 (before the start of the intervention), 7 and 14. Method of measurement: questionnaire survey (Patient self-report).
© Copyright 2025. All Rights Reserved by MedPath